Maternal administration of busulfan before in utero transplantation of human hematopoietic stem cells enhances engraftments in sheep

Experimental Hematology

Volumn 40, Issue 6, 2012, Pages 436-444

  Abe, Tomoyuki ^a,b,c   Masuda, Shigeo ^b   Tanaka, Yujiro ^b,f   Nitta, Suguru ^a   Kitano, Yoshihiro ^d   Hayashi, Satoshi ^d   Hanazono, Yutaka ^b,e   Nagao, Yoshikazu ^a,c  

^a UTSUNOMIYA UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^d NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APPETITE DISORDER; ARTICLE; BONE MARROW SUPPRESSION; CD34 SELECTION; COLONY FORMING UNIT; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DRUG ACTIVITY; ENGRAFTMENT; EWE; FEMALE; FEVER; HEMATOPOIESIS; HEMORRHAGIC COLITIS; HUMAN; HUMAN CELL; IN UTERO STEM CELL TRANSPLANTATION; LAMB; LEUKOCYTE COUNT; MEMBRANE RECONSTITUTION; NEUTROPHIL COUNT; NONHUMAN; PLACENTA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BASE SEQUENCE; BUSULFAN; DNA PRIMERS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MATERNAL-FETAL EXCHANGE; MODELS, ANIMAL; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; SHEEP; TRANSPLANTATION, HETEROLOGOUS;

ANIMALIA; OVIS ARIES;

EID: 84863404792     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.01.018     Document Type: Article

References (30)

1. Carrier E., Lee T.H., Busch M.P., Cowan M.J. Induction of tolerance in nondefective mice after in utero transplantation of major histocompatibility complex-mismatched fetal hematopoietic stem cells. Blood 1995, 86:4681-4690.
2. Lutzko C., Meertens L., Li L., et al. Human hematopoietic progenitors engraft in fetal canine recipients and expand with neonatal injection of fibroblasts expressing human hematopoietic cytokines. Exp Hematol 2002, 30:801-808.
3. Fujiki Y., Fukawa K., Kaneyama K., et al. Successful multilineage engraftment of human cord blood cells in pigs after in utero transplantation. Transplantation 2003, 75:916-922.
4. Flake A.W., Harrison M.R., Adzick N.S., Zanjani E.D. Transplantation of fetal hematopoietic stem cells in utero: the creation of hematopoietic chimeras. Science 1986, 233:776-778.
5. Tutschka P.J., Santos G.W. Bone marrow transplantation in the busulfan-treated rat. Relationship between myelosuppresion and immunosupression for conditioning bone marrow recipients. Transplantation 1977, 24:52-62.
6. Cavo M., Bandini G., Benni M., et al. High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma. Bone Marrow Transplant 1998, 22:27-32.
7. Hassan M. The role of busulfan in bone marrow transplantation. Med Oncol 1999, 16:166-176.
8. Ashizuka S., Peranteau W.H., Hayashi S., Flake A.W. Busulfan-conditioned bone marrow transplantation results in high-level allogenic chimerism in mice made tolerant by in utero hematopoietic cell transplantation. Exp Hematol 2006, 34:359-368.
9. Yeager A.M., Shinn C., Pardol D.M. Lymphoid reconstitution after transplantation of congenic hematopoietic cells in busulfan-treated mice. Blood 1991, 78:3312-3316.
10. Yoder M.C., Cumming J.G., Hiatt K., Mukherjee P., Williams D.A. A novel method of myeloablation to enhance engraftment of adult bone marrow cells in newborn mice. Biol Blood Marrow Transplant 1996, 2:59-67.
11. Chapel S., Veng-Pedersen P., Hohl R.J., Schmidt R.L., McGuire E.M., Widness J.A. Changes in erythropoietin pharmacokinetics following busulfan-induced bone marrow ablation in sheep: evidence for bone marrow as a major erythropoietin elimination pathway. J Pharmacol Exp Ther 2001, 298:820-824.
12. Nagao Y., Abe T., Hasegawa H., et al. Improved efficacy and safety of in utero cell transplantation in sheep using an ultrasound-guided method. Cloning Stem Cells 2009, 11:281-285.
13. Deeg H.J., Shuler U.S., Shulman H., et al. Myeloablation by intravenous busulfan and hematopoietic reconstitution with autologous marrow in a canine model. Biol Blood Marrow Transplant 1999, 5:316-321.
14. Kang E.M., Hsieh M.M., Metzger M., et al. Busulfan pharmacokinetics, toxicity, and low-dose conditioning for autologous transplantation of genetically modified hematopoietic stem cells in the rhesus macaque model. Exp Hematol 2006, 34:132-139.
15. Mauch P., Down J.D., Warhol M., Hellman S. Recipient preparation for bone marrow transplantation. I. Efficacy of total-body irradiation and busulfan. Transplantation 1988, 46:205-210.
16. Santos G.W., Tutschka P.J. Marrow transplantation in the busulfan-treated rat: preclinical model of aplastic anemia. J Natl Cancer Inst 1974, 53:1781-1785.
17. Nau H. Species differences in pharmacokinetics and drug teratogenesis. Environ Health Perspect 1986, 70:113-129.
18. Igarashi T., Satoh T. Sex and species differences in glutathione S-transferase activities. Drug Metabol Drug Interact 1989, 7:191-212.
19. Boyd R.D., Haworth C., Stacey T.E., Ward H.T. Permeability of the sheep placenta to unmetabolized polar non-electrolytes. J Physiol 1976, 256:617-634.
20. Brinster C.J., Ryu B.Y., Avarbock M.R., Karagenc L., Brinster R.L., Orwig K.E. Restoration of fertility by germ cell transplantation requires effective recipient preparation. Biol Reprod 2003, 69:412-420.
21. Ho A.Y., Pagliuca A., Kenyon M., et al. Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning. Blood 2004, 104:1616-1623.
22. Galtier P., Alvinerie M. Pharmacological basis for hepatic drug metabolism in sheep. Vet Res 1996, 27:363-372.
23. Hassan M., Ehrsson H. Metabolism of 14C-busulfan in isolated perfused rat liver. Eur J Drug Metab Pharmacokinet 1987, 12:71-76.
24. Hassan M., Ehrsson H. Urinary metabolites of busulfan in the rat. Drug Metab Dispos 1987, 15:399-402.
25. Hassan M., Oberg G., Ehrsson H., et al. Pharmacokinetic and metabolic studies of high-dose busulphan in adults. Eur J Clin Pharmacol 1989, 36:525-530.
26. Wales R.G., Murdoch R.N. Changes in the composition of sheep fetal fluids during early pregnancy. J Reprod Fertil 1973, 33:197-205.
27. Alexander D.P., Britton H.G., Nixon D.A. Observation on the isolated foetal sheep with particular reference to the metabolism of glucose and fructose. J Physiol 1966, 185:382-399.
28. McDougall E.I. The composition of foetal fluids of sheep at different stages of gestation. Biochem J 1949, 45:397-400.
29. Sasaki K., Nagao Y., Kitano Y., et al. Hematopoietic microchimerism in sheep after in utero transplantation of cultured cynomolgus embryonic stem cells. Transplantation 2005, 79:32-37.
30. Abe T., Masuda S., Ban H., et al. Ex vivo expansion of human HSCs with Sendai virus vector expressing HoxB4 assessed by sheep in utero transplantation. Exp Hematol 2011, 39:47-54.